← Browse by Condition
Medical Condition

refractory systemic lupus erythematosus

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06513429
Recruiting

IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)

Enrollment
6 pts
Location
China
Sponsor
Peking University Third Hospit...
View Trial →